rs6265, BDNF;BDNF-AS

N. diseases: 272
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE Gene-by-environment studies investigating the impact of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) and the Brain Derived Neurotrophic Factor (BDNF) Val66Met polymorphisms by life events on mental health and behaviour problems have been inconclusive. 27267363 2016
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE In spite of abundant evidence that Val66Met BDNF polymorphism has an impact on several different neurological or psychiatric disorders, we conclude that a major clinical impact of Val66Met polymorphism as a disease modifier in temporal lobe epilepsy is probably unlikely. 19896331 2010
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE In humans and knock-in mice with a loss of function BDNF SNP (Val66Met), the functionality of this circuit was altered, resulting in social behavioral changes in human and mice. 30992540 2019
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE A single nucleotide polymorphism (val66met) in the brain derived neurotrophic factor (BDNF) gene has been shown to be a risk factor for a number of psychiatric disorders, including schizophrenia. 20957650 2010
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE Several polymorphisms in BDNF have been reported and studied in psychiatric disorders but the most frequent is the p.Val66Met (rs6265G > A) single nucleotide polymorphism (SNP), with functional effects on the intracellular trafficking and secretion of the protein. 19603419 2010
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE This study provides evidence that Val66Met is associated with cortical maturation in children and adolescents with and without psychiatric disorders. 29288952 2018
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. 17217930 2007
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE Recent studies show that the Val(66)Met BDNF polymorphism correlates with various psychiatric disorders, including anxiety, but there are several differences between experimental and clinical studies. 24051499 2013
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE A single-nucleotide polymorphism (rs6265) in the human gene, resulting in a valine to methionine substitution in the pro-BDNF protein, was thought to associate with psychiatric disorders and might play roles in the individual difference of cognitive abilities. 19424874 2009
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE Variants in BDNF, in particular the functional Val66Met polymorphism (rs6265), have been found to be associated with a number of psychiatric disorders, cognitive function, and obesity. 24708359 2015
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE Association of the valine/methionine variant at codon 66 (Val66Met) of brain derived neurotrophic factor (BDNF) has been reported inconsistently across a spectrum of psychiatric disorders. 18797396 2008
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE Thus, considering that these parameters are determinant for protein interactions and, consequently, protein function; the alterations observed throughout the MD analyses may be related to the functional impairment of BDNF upon V66M mutation, as well as its involvement in psychiatric disorders. 30998730 2019
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE Altered hippocampal volume, the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism, and neuroticism have each been implicated in the etiology of psychiatric disorders, especially depression. 18548532 2009
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE The Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) is associated with psychiatric disorders and regional gray matter volume (rGMV) in adults. 26830347 2016
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE Several polymorphisms in BDNF have been reported and studied in psychiatric disorders but the most frequent is the p.Val66Met (rs6265G > A) single nucleotide polymorphism (SNP), with functional effects on the intracellular trafficking and secretion of the protein. 19603419 2010
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE G196A, a common polymorphism of the BDNF gene, not only affects cognitive and motor processes, but also is associated with various psychiatric disorders. 20085561 2010
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE Val66Met (also known as rs6265 or G196A), the only known functional polymorphism of the BDNF gene, has been widely studied and considered to be associated with risk of some psychiatric disorders such as bipolar disorder and schizophrenia. 26503495 2015
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE A variation in the BDNF gene (val66met) affects the function of BDNF in neurons, predicts variation in human memory, and is associated with several neurological and psychiatric disorders. 15537879 2004
Abnormal behavior
CUI: C0233514
Disease: Abnormal behavior
0.100 GeneticVariation BEFREE Here we comprehensively review the role and relevance of the Val66Met polymorphism in psychiatric disorders, with emphasis on suicidal behavior and anxiety, eating, mood and psychotic disorders. 25824305 2015
Acute Cerebrovascular Accidents
CUI: C0751956
Disease: Acute Cerebrovascular Accidents
0.020 GeneticVariation BEFREE Val66Met BDNF gene polymorphism influences human motor cortex plasticity in acute stroke. 25241287 2015
Acute Cerebrovascular Accidents
CUI: C0751956
Disease: Acute Cerebrovascular Accidents
0.020 GeneticVariation BEFREE Previous studies show that the BDNF Val66Met variant negatively affects motor learning and severity of acute stroke. 24523540 2014
Acute Chest Syndrome
CUI: C0742343
Disease: Acute Chest Syndrome
0.010 GeneticVariation BEFREE Because the expression of BDNF is influenced by genetic polymorphisms, in this study we investigated the association between the BDNF polymorphism val66met and both the risk of depression in ACS and the treatment response. 26795846 2016
Acute Coronary Syndrome
CUI: C0948089
Disease: Acute Coronary Syndrome
0.010 GeneticVariation BEFREE BDNF val66met polymorphism and depressive disorders in patients with acute coronary syndrome. 26795846 2016
Acute leukemia
CUI: C0085669
Disease: Acute leukemia
0.010 GeneticVariation BEFREE The BDNF Val66Met polymorphism may contribute to development of depressive symptomatology in patients undergoing stressful life events, such as diagnosis of acute leukemia and preparation for HSCT. 22652301 2013
Addictive Behavior
CUI: C0085281
Disease: Addictive Behavior
0.010 GeneticVariation BEFREE Recent studies showed an association between a functional polymorphism of BDNF gene (Val66Met) and the susceptibility to methamphetamine addiction. 25168604 2014